I wanted to let you, our Sacred Plant community and followers, know the time has come for me to return to the place my journey began back in 2011, United Patients Group, and so this letter is both good bye and thank you.
Medical studies published in the world’s top medical journals have shown that cannabidiol (CBD) can be used to reduce the effects of cognitive decline caused by conditions such as dementia and Alzheimer’s disease.
Debbie Wilson: The Journey Back from Traumatic Brain Injury and Dementia, with a Side of Disappearing Diabetes
“In 2013, I had been diagnosed with dementia, and I could tell I was disappearing. I couldn’t even remember how to make myself coffee—or tell you how I take that cup of coffee.”
This November, United Patients Group is celebrating National Epilepsy Awareness Month. This month has a special significance for us, as cannabis has shown to be very effective in treating various forms of epilepsy, reducing seizures, and improving the quality of life for many epilepsy patients. This month, we are especially dedicated to spreading awareness about cannabis and how it can be used to treat epilepsy.
We started the tincture in 2013. Within three months seizures had reduced by at least 50 percent. By six months people were commenting on her speech being clear, and she was becoming less dependent on her wheelchair or other aids.
Other forms of epilepsy seem to respond just as well to high-CBD therapy. Dr. Margaret Gedde found that child patients with Dravet syndrome, Doose syndrome and Lennox-Gastaut syndrome all improved with extract use.
A nationally renowned pediatric neurologist at Saint Barnabas has gotten FDA approval to study whether a cannabis-based drug could prevent seizures in children diagnosed with severe forms of epilepsy.
Shuker has new hope as a result of research on cannabidiol, or CBD, a non-psychoactiveCBD element in the marijuana plant that doctors in Colorado have shown to be effective against seizures.
New Clinical trials show how ingested cannabis acts as a novel therapeutic agent in Central Nervous System (CNS) disorders, including epilepsy and neurodegenerative diseases, such as multiple sclerosis (MS), Alzheimer’s (AD), Parkinson’s(PD), Huntington’s Disease (HD).